Categories 2018

1. Best Technological Innovation
2. Venture Financing Deal of the Year
3. Best Company in an Emerging Market
4. The In Vivo Award for Best Medtech Partnership/Alliance
5. Most Innovative Clinical Trial
6. Most Innovative Team or Innovator of the Year
7. Best Proof-of-Value of an Innovation
8. Entrepreneur of the year
9. Lifetime Achievement Award
   
   

1. Best Technological Innovation

Innovation is the life blood of the medtech industry. This Award will recognize the efforts of an individual, team, or company that developed an innovative medical device or diagnostic that makes significant contributions to advancing patient treatment, and was launched between January 1, 2017- May 31, 2018. The judges will be looking for the product that represents the most innovative new approach to care by addressing an unmet clinical need; by changing the practice of health care to be more effective, efficient or less error-prone; or by expanding technology to new patient populations.
To be eligible, entrants must have played a role in the core project for the product.

To enter this category, please provide the following:

• The name of the individual, team or company, including an outline of their role(s).
• Details of the product; i.e. type of product, name(s), procedure, patient segment(s)
• Provide evidence of the impact that the product has had, or potentially could have, on the patient population and addressing unmet medical needs
• Describe any unique strategies used to identify market needs, prototype, bench test, develop clinical protocols or take on other steps of the innovation process.
• If available, please provide documentation (URL) in support of the achievements described

2. Venture Financing Deal of the Year

Start-ups need solid financial backing to help take their innovations through the journey from bench to market. This award will recognize the fundraising efforts of a start-up or emerging company with potentially disruptive technologies, and judges will be looking out for fundraising strategy, amount raised, the business case put forward to win investors' backing, deal structure, the calibre of investors, unusual syndicates among other things.
This award is open only to companies that are raising/have raised the funds (i.e., not bankers or agents), and it is for earlier-stage venture financing rounds i.e. Series A or Series B. To be eligible, the financing deal in question must be ongoing or completed between January 1, 2017- May 31, 2018.

To enter this category, please provide the following:

• Please provide details of your company and the technology/service you are offering.
• Outline the form of financing, the structure of the deal and how much was raised.
• How close was the final amount raised to your initial fundraising objectives?
• Please describe how this fundraising was particularly creative. How does this financing round set a new benchmark for other deals?
• Who were the investors that participated this round? Please provide details of the investors' background and history of financing medtech/life sciences companies.
• Did the funding succeed in other ways, such as bringing on board a new kind of investor?
• How will the money be used?
• Please give evidence of early value creation from the deal.

3. Best Company in an Emerging Market

The Best Company in an Emerging Market Award seeks to reward the growing R&D-based medical technology industry founded in areas beyond its traditional geographic borders of North America, Western Europe and Japan.

This Award is open to any research-based medical technology company that has its headquarters in an emerging market.
The judges will be looking for excellent performance across a range of business activities between January 1, 2017- May 31, 2018. This could mean anything from growing sales and profits to launching new products, or signing a transformative new deal.

Companies eligible for this Award are those based in emerging markets in Asia, central and eastern Europe, Central and South America, the Middle East and Africa.
To enter this category, please answer the following:

• Please give the name of the entering company and country where it is headquartered
• What has been this company’s most significant achievement during the year?
• Give details of what this company has achieved in terms of:
  – Growth in sales and profits
  – Signing important new deals
  – Introducing new products onto the market
  – Producing a promising new product pipeline
  – Operational improvements, particularly after restructuring, or changing the focus of the business.

4. The In Vivo Award for Best Medtech Partnership/Alliance

This Award will be presented to two or more organizations whose joint activity during 2017 has set a new benchmark in partnering activity. Partnerships could take place between multiple medical technology and/or pharmaceutical companies or between a medical technology company and a contract research organization, research institute, non-profit, or cooperative group.
To be eligible, the collaborative partnership activity in question must be ongoing or completed between January 1, 2017- May 31, 2018.
Entrants must have played a role in the collaborative partnership activity, and all joint parties must be disclosed in the application.

To enter this category, please provide the following:

• Provide the names of organizations involved and basic details of the partnership.
• Why was the partnership novel?
• How does this partnership set a new benchmark for other deals?
• How has partnership achieved an outcome that would not have been possible if partnership had not been created?
• If available, please provide documentation (URL) in support of the achievements described.

5. Most Innovative Clinical Trial

This Award will recognize the device or diagnostic clinical trial that has had the greatest impact in 2017/8 and is expected to lead to an advance in healthcare. The judges will be looking to reward the clinical trial with the largest commercial impact, highest impact on patient population, the greatest disruption in a market, or the advancement of clinical trial design. This might include the first demonstration of a clear clinical effect for a new device/diagnostic in an area of unmet medical need, a pivotal study of a new device/diagnostic with a breakthrough technology or mechanism of action, or a major study of a potential new or expanded indication for an already marketed product.
To be eligible, results for the study in question must have been presented in the public domain between January 1, 2017- May 31, 2018.
Entrants must have played a role in the clinical study, and all joint parties must be disclosed in the application.

To enter this category, please provide the following:

• Full details of the study; i.e. trial name (title, protocol ID, trial identifier), Phase, disease type and patient segment(s) studied, sponsor(s), and the primary device/diagnostic(s) tested.
• Summarize the major findings of the study, including all primary/co-primary and main secondary endpoints, and safety endpoints.
• Provide evidence supporting uniqueness and advancement of knowledge in an area of unmet medical need or clinical trial design.
• How do these findings represent a potential leap forward in therapy?
• Documentation (URL) of publicly available trial results required; i.e. press release, conference abstract/presentation, clinical study report synopsis or other publication.

6. Most Innovative Team or Innovator of the Year

This Award will recognize the medical technology team who have made significant contributions in the device and diagnostic space between January 1, 2017- May 31, 2018. The judges will be looking to reward the high performing team that has been most successful in reaching its goals, adopted innovative working practices, achieved major milestones within expected timelines, and contributed to the advancement of medical technology for unmet medical needs.
To be eligible, the core project for the nominated team must be ongoing or completed during 2017/8.  
Entrants must have played a role in the core project for the product.

To enter this category, please provide the following:

• The company’s name, the team or individual being entered and basic details of its core project during 2017/8.
• What was the greatest achievement of the team or individual during the qualifying period?
• How did the individual or members/functions of the team work together to achieve its goals?
• How does the achievement contribute to advancing medical technology for unmet medical needs?
• What innovative work practices has the team or individual adopted to drive success?
• If you believe that this team or individual is particularly outstanding, but for reasons not covered in the questions above, please give relevant details
  
  

7. Best Proof-of-Value of an Innovation

This Award will recognize a company or division that has taken an innovative or creative approach to demonstrating the value of its product(s) to the health-care sector.  Examples may include approaches to data collection, partnerships with providers or insurers, or other models that serve to demonstrate a products value to providers, patients and other health-care stakeholders between January 1, 2017- May 31, 2018.

To enter this category, please provide the following:

• The company’s name, the team being entered and basic details of the core project.
• A description of the proof-of-value strategy, its intended outcomes and metrics.
• How has the strategy achieved an outcome that would not have been possible if it had not been created?
• What makes the strategy particularly novel?
• How has the approach set a new model or benchmark for other products or markets?
• If available, please provide documentation (URL) in support of the achievements described

8. Entrepreneur of the Year

The winner of this Award will be an individual with an impressive track record of starting up medtech businesses, taking products down the regulatory/clinical pathway and into the market. Or could be a more commercial-focused individual who has shown the ability to spot a business opportunity and capitalize on it, break a new technology into the marketplace, successfully scaled up a business and taken it through to an exit.

For this Award, candidates must be nominated by a third party. The nomination should outline in no more than 500 words the nominee's track record of entrepreneurship and why they are worthy of this Award.

All nominations must include:

• The name of the nominee
• The job title of the nominee (if applicable)
• The company name (if applicable)
• Your contact details
• The contact details of the nominee
• A summary of up to 500 words of why you think your nominee is worthy of receiving the Entrepreneur of the Year Award.

9. Lifetime Achievement Award

For this special Award, candidates must be nominated by a third party.  The nomination should outline in no more than 500 words what the nominee has accomplished during his or her career and say why they are worthy of this Award.

All nominations must include:

• The name of the nominee
• The job title of the nominee (if applicable)
• The company name (if applicable)
• Your contact details
• The contact details of the nominee
• A summary of up to 500 words of why you think your nominee is worthy of receiving the Lifetime Achievement Award